Article
Validation of a Human Papillomavirus (HPV) DNA Cervical Screening Test That Provides Expanded HPV Typing.
Journal of clinical microbiology - 1 May 2018
Demarco Maria, Carter-Pokras Olivia, Hyun Noorie, Castle Philip E, He Xin, Dallal Cher M, Chen Jie, Gage Julia C, Befano Brian, Fetterman Barbara, Lorey Thomas, Poitras Nancy, Raine-Bennett Tina R, Wentzensen Nicolas, Schiffman Mark
Abstract excerpt
As cervical cancer screening shifts from cytology to human papillomavirus (HPV) testing, a major question is the clinical value of identifying individual HPV types. We aimed to validate Onclarity (Becton Dickinson Diagnostics, Sparks, MD), a nine-channel HPV test recently approved by the FDA, by assessing (i) the association of Onclarity types/channels with precancer/cancer; (ii) HPV type/channel agreement...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
